Yun F. Zeng
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies.
Journal: Journal of hematology & oncology
Published: December 26, 2025
A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies.
Journal: Journal of hematology & oncology
Published: December 26, 2025
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
Spatial distribution patterns and causal mechanisms of rainfall-induced clustered landslides: A case study from Southwestern Yunnan Province, China.
Journal: PloS one
Published: November 21, 2025
Triaxial test investigation of the reinforcement effect of Acacia dealbata roots on mountain red soil.
Journal: Scientific reports
Published: August 30, 2025
Knocking Out DNMT1 Enhances the Inhibitory Effect of NK Cells on Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: July 04, 2025
Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.
Journal: Research and practice in thrombosis and haemostasis
Published: July 03, 2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.
Journal: Haematologica
Published: May 15, 2025
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial.
Journal: Clinical and experimental medicine
Published: February 11, 2025
Identification of glucuronic acid as a biomarker of poor prognosis in acute myeloid leukemia based on plasma metabolomics.
Journal: Clinical and experimental medicine
Published: October 30, 2024
DNMT1 inhibition improves the activity of memory-like natural killer cells by enhancing the level of autophagy.
Journal: Molecular biology reports
Published: October 09, 2024
Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect.
Journal: Hematological oncology
Published: August 15, 2024
Last Updated: 09/26/2026